Possibilities of vaginal biotope correction in pregnant women after application of auxiliary reproductive technologies

Authors

DOI:

https://doi.org/10.18370/2309-4117.2021.60.40-45

Keywords:

assisted reproductive technologies, vaginal biocenosis, progesterone, pH, probiotics

Abstract

Research objective: to determine the role and effectiveness of the proposed therapeutic and prophylactic complex in the correction of vaginal biocenosis disorders in the dynamics of pregnancy in pregnant women after assisted reproductive technologies (ART) to improve the tactics of antenatal observation and prevention of obstetric and perinatal complications.
Materials and methods. 299 pregnant women were examined: the main group included 249 women with pregnancy after ART, the control group consisted of 50 pregnant women with spontaneous pregnancy.
Therapeutic and prophylactic measures for pregnant women after ART included: micronized progesterone, magnesium oxide, folic acid, L-arginine aspartate, ω-3-polyunsaturated fatty acids, long-term psychological correction (on the eve of the ART program, at 8–10 weeks, 16–18 weeks and 28–30 weeks of pregnancy). The drug for antibiotic therapy for local sanitation of the genital tract was chosen taking into account the sensitivity to antibiotics of certain microbial associates and was prescribed for 7–10 days.
At the second stage of sanitation of the genital tract probiotics were prescribed under the control of pH-metry to maintain the acidic environment of the vaginal contents, colonize the vagina and the vaginal part of the cervix with lactobacilli.
Results. There was a significant decrease in the proportion of women with a large number of epithelial cells in the main groups, which are a sign of alterative inflammation, and this is coincides with a similar indicator in the control group. Women with moderate leukocyte count and mixed Gram-negative microflora prevailed in IB, IIB and IIIB subgroup, who received conventional therapy. There was no significant difference in IIIA and IIIB subgroups.
In the vaginal biocenosis significantly increased the Lactobacillus spp. content against the background of probiotics with local and general action in ІА, ІІА and ІІІА subgroups. The average Lactobacillus spp. concentration was significantly different from the average indicators of subgroups receiving conventional therapy for vaginal sanitation, with a significant decrease in the biocenosis of aerobic and anaerobic microorganisms and Candida albicans, which indicates the effectiveness of the proposed two-stage treatment.
Conclusions. The proposed improved two-stage sanitation of the genital tract with a selective probiotic against the background of long-term progesterone and magnesium support ensures the stabilization of the vaginal pH at the physiological level corresponding to the normocenosis, and contributes to a significant increase in Lactobacillus spp. within the physiological norm with a significant decrease of Candida albicans concentration in the biotope, as well as opportunistic pathogens of aerobic and anaerobic origin. This is provides conditions for the prolongation of pregnancy in women after ART treatment cycles.

Author Biographies

L.M. Vygivska, Bogomolets National Medical University, Kyiv

PhD, assistant professor, Obstetrics and Gynecology Department No. 3

V.O. Beniuk, Bogomolets National Medical University, Kyiv

MD, professor, head of the Obstetrics and Gynecology Department No. 3

I.V. Maidannyk, Bogomolets National Medical University, Kyiv

PhD, assistant professor, Obstetrics and Gynecology Department No. 3

I.A. Usevych, Bogomolets National Medical University, Kyiv

PhD, assistant professor, Obstetrics and Gynecology Department No. 3

L.D. Lastovetska, Bogomolets National Medical University, Kyiv

PhD, assistant professor, Obstetrics and Gynecology Department No. 3

Y.G. Drupp, Bogomolets National Medical University, Kyiv

PhD, assistant professor, Obstetrics and Gynecology Department No. 3

V.V. Kurochka, Bogomolets National Medical University, Kyiv

PhD, assistant, Obstetrics and Gynecology Department No. 3

References

  1. Zhuk, S.I., Us, I.V., Shljahtina A.A. “Oral probiotics are the key to a successful pregnancy.” Health of Women 10.116 (2016): 55–56.
  2. Zhuk, S.I., Shljahtina, A.A. “Women's biotope management – new approaches.” Health of Women 5.132 (2018): 34–36.
  3. Lahtin, M.V., Lahtin, V.M., Bajrakova, A.L., et al. “Multi-node concept of human biotope microbiocenosis.” Clinical and laboratory diagnostics 59.9 (2014): 83.
  4. Order of the Ministry of Health of Ukraine No. 417 of 15.07.2011 “Methodological recommendations for providing outpatient obstetric and gynecological care”.
  5. Order of the Ministry of Health of Ukraine No. 787 of 09.09.2013 “Procedure for the use of assisted reproductive technologies in Ukraine”.
  6. Order of the Ministry of Health of Ukraine No. 234 of 10.05.2007 “On the organization of prevention of nosocomial infections in obstetric hospitals”.
  7. Order of the Ministry of Health of Ukraine No. 906 of 27.12.2006 “Perinatal infections“.
  8. Markin, L.B., Shahova, O.V., Popovych, A.I. “Complex therapy of recurrent chronic genital chlamydia.” Actual Problems of Pediatrics, Obstetrics and Gynecology 2 (2012): 1–6.
  9. Nagornaja, V.F., Moskalenko, T.J., Gricenko A.A. “The pH of the vaginal secretion in the assessment of the vaginal microbiota during pregnancy.” Health of Women 6 (2015): 90–93.
  10. Podol'skyj, V.V., Kagramanjan A.L. “Therapeutic and preventive measures aimed at correcting the microbiocenosis of urogenital organs in women of fertile age, residents of the agricultural region of Ukraine.” Neonatology, Surgery, and Perinatal Medicine 5.2 (2015): 66–71.
  11. Prilepskaja, V.N., Letunovskaja, A.B., Donnikov, A.E. “Vaginal microbiocenosis and cytokine gene polymorphism as a marker of a woman's health (literature review).” Gynecology 17.2 (2015): 4–13.
  12. Sejthanova, B.T., Shapambaev, Z.Z., Olzhaeva, R.R., Kalmenova, P.E. “Microbiocenosis of the vagina and intestines of pregnant women.” Science and Healthcare 1 (2014): 70–71.
  13. Sinjakova, A.A. “Modern ideas about the vaginal microbiocenosis and its impact on pregnancy outcomes.” Journal of Obstetrics and Women's Diseases 66.6 (2017): 89–100.
  14. Sinjakova, A.A., Shipicyna, E.V., Rybina, E.V., et al. “Vaginal microbiocenosis in the first trimester of pregnancy in women with a history of miscarriage.” Journal of Obstetrics and Women's Diseases 65.4 (2016): 44–9. DOI: 10.17816/JOWD65444-49
  15. Tumanova, L.E., Kolomiec, E.V. “Vaginal microbiocenosis in pregnant women with a history of various types of infertility.” Ukrainian Journal of Perinatology and Pediatrics 2.82 (2020): 68–75. DOI: 10.15574/PP.2020.82.68
  16. Hrjanin, A.A., Reshetnikov, O.V. “Chlamydia infection: from science to practice.” Kyiv: Tetris-print (2012): 180 p.
  17. Shalepo, K.V. “Evaluation of modern methods of laboratory diagnostics of bacterial vaginosis.” Journal of Obstetric and Women's Diseases 63. 1 (2014): 26–32.
  18. Anderson, B.L., Cu-Uvin, S., Raker, C.A., et al. “Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women.” Acta Obstet Gynecol Scand 90.5 (2011): 510.
  19. Freitas, A.C., Chaban, B., Bocking, A. “The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women.” Scientific Reports 7 (2017). Article number: 9212.
  20. Kovachev, S. “Defence factors of vaginal lactobacilli.” Critical Reviews in Microbiology 44.1 (2018): 31–39.
  21. Macklaim, J.M., Gloor, G.B., Anukam, K.C., et al. “At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1.” Proc Natl Acad Sci USA 108.1 (2011): 4688–4695. DOI: 10.1073/pnas.1000086107
  22. Petricevic, L., Domig, K., Nierscher, F.J., et al. “Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery.” Sci Rep 4 (2014): 51362. DOI: 10.1038/srep05136
  23. Rampersaud, R., Planet, P.J., Randis, T.M., et al. “Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners.” J Bacteriol 193.5 (2011): 1034–41.
  24. Roberts, C.L., Morris, J.M., Rickard, K.R., et al. “Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth.” BMC pregnancy and childbirth 11 (2011): 19.
  25. Sherrard, J., Donders, G., White, D., Jensen, J.S. “European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011.” International journal of STD & AIDS 22.8 (2011): 421–9.
  26. Zodzika, J., Rezeberga, D., Jermakova, I., et al. “Factors related to elevated vaginal pH in the first trimester of pregnancy.” Acta obstetricia et gynecologica Scandinavica 90.1 (2011): 41–6.

Downloads

Published

2021-09-24

How to Cite

Vygivska, L., Beniuk, V., Maidannyk, I., Usevych, I., Lastovetska, L., Drupp, Y., & Kurochka, V. (2021). Possibilities of vaginal biotope correction in pregnant women after application of auxiliary reproductive technologies. REPRODUCTIVE ENDOCRINOLOGY, (60), 40–45. https://doi.org/10.18370/2309-4117.2021.60.40-45

Issue

No. 60 (2021)

Section

Pregnancy and childbirth

License

Copyright (c) 2021 Л.M. Вигівська, В.О. Бенюк, I.В. Maйданник, I.A. Усевич, Л.Д. Ластовецька, Ю.Г. Друпп, В.В. Курочка

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.